Rapid digital transformation occurring in life science companies
The IDC MarketScape states that “as an industry, life science lags behind its counterparts in other industries such as retail and financial services in digital transformation of business processes. But, great strides are being made, especially with the help of technology vendors that have expertise in transforming business processes at life science companies, leveraging digital competencies in areas such as cloud computing, mobility, social business, and big data and analytics.”
The report highlights that “PwC serves a large number of customers in each major sector of life science: pharmaceutical, biotech, and medical devices. Over 80% of PwC's life sciences customers are large companies with revenue exceeding $1 billion. These customers are located mostly in North America, with significant numbers in Europe, Asia/Pacific, and Latin America. PwC was rated highly by its customers for industry expertise and technical capabilities.”
Commenting on achieving this positioning, Doug Strang, PwC’s Global Pharmaceuticals and Life Sciences Advisory leader, said: “We are excited to learn the IDC MarketScape places PwC as a leader in Worldwide Life Science Sales and Marketing Digital Transformation. We are proud of the innovation and value we provide for our clients using our industry expertise and technical capabilities.”
(IDC MarketScape for Worldwide Life Science Sales and Marketing Digital Transformation 2016 Vendor Assessment, #US40510716, July 2016)
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilises a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
1. For more information about how PwC's pharmaceuticals and life sciences practice helps pharmaceutical, biotech and medical device clients develop future focused business strategies and implement the time critical programmes and procedures essential to success within worldwide regulatory frameworks, visit https://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences.html
2. To find out more about how PwC has been evaluated by leading business, technology and industry analysts visit www.pwc.com/analystviews
3. At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 157 countries with more than 208,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
©2016 PwC. All rights reserved
Robert DonnellyPwC Global Analyst RelationsUnited Statesrobert.firstname.lastname@example.org+1 917 471 3355